CARR vs RNAC · P/E 43, rev $5.15B vs P/E 2.1, rev $38.9M
Carrier Global Corp (CARR) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the CARR and RNAC stock pages for the full models.
Not investment advice.